Dr. Tara Carr, MD (she/her) is a Internist in Tucson, AZ with over 16 years of experience. What is your opinion of Dr. Tara Carr, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 16 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Tara Carr, MD has received over $89,199 which includes payments from the following companies:
$43,071.04 from AstraZeneca Pharmaceuticals LP
$13,521.71 from Regeneron Healthcare Solutions, Inc.
$10,322.53 from Novartis Pharmaceuticals Corporation
$7,920.75 from AstraZeneca UK Limited
$7,187.50 from AIMMUNE THERAPEUTICS, INC.
$4,652.26 from F. Hoffmann-La Roche AG
$1,704.41 from sanofi-aventis U.S. LLC
$200.06 from Meda Pharmaceuticals, Inc.
$182.51 from Dyax Corp
$108.43 from GENZYME CORPORATION
$96.27 from Merck Sharp & Dohme Corporation
$59.42 from Stryker Corporation
$42.42 from Horizon Pharma plc
$38.30 from Mylan Specialty L.P.
$34.95 from Pfizer Inc.
$24.27 from GlaxoSmithKline, LLC.
$22.37 from CSL Behring
$10.63 from Shire North American Group Inc
Payments received by Dr. Tara Carr, MD were from the following categories:
$69,670.51 Consulting Fee
$10,337.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!